‘administered intravenously administered intravenously showed great promise in the laboratory, and there was some anecdotal data in cancer patients, but no one has ever really a detailed study running on people. Vitamin C does not cost much and has very low in toxicity, making it a particularly desirable means for further studies. Has recent research from NIH staff this study demonstrated when given in sufficient amounts intravenously, vitamin C converts to hydrogen peroxide when certain non-Hodgkin ‘s lymphoma cells used in the laboratory, the converted hydrogen peroxide kills while surrounding healthy surrounding healthy cells intact.. ‘This is a very unique study for a number of patients who have really run out of options,’said Daniel Monti, director of the Myrna Brind Center of Integrative Medicine, and primary investigator of the study.
The Jefferson Kimmel Cancer Center is one selected from the National Cancer Institute National Cancer Institute-designated Clinical Cancer Centers in the nation. The KCC more than 100 clinical trials from each year on the prevention and treatment of cancer, while its basic scientists a better understanding the development and behavior of the disease win. It is the cornerstone of the Jefferson Cancer Network , a consortium of more than 20 institutions. Dedicated to improving cancer treatment and clinical research.
Previous studies in humans are flawed because the vitamin C was given orally versus intravenously, said Monti, the problem with that is the oral route tightly limits the amount of vitamin C.Continue Reading